Nisa Investment Advisors’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.05M Sell
6,111
-169
-3% -$53.5K 0.01% 616
2026
Q1
$2.02M Sell
6,280
-1,490
-19% -$461K 0.01% 607
2025
Q4
$2.29M Buy
7,770
+641
+9% +$119K 0.01% 598
2025
Q3
$378K Buy
7,129
+6,500
+1,033% +$315K ﹤0.01% 1093
2025
Q2
$26.4K Buy
629
+295
+88% +$11.2K ﹤0.01% 1803
2025
Q1
$12.6K Buy
334
+263
+370% +$16.4K ﹤0.01% 2036
2024
Q4
$5.46K Buy
71
+13
+22% +$941 ﹤0.01% 2255
2024
Q3
$3.34K Buy
+58
New +$3.13K ﹤0.01% 2303
2023
Q1
Sell
-8
Closed 2661
2022
Q4
$0 Buy
+8
New +$249 ﹤0.01% 2681
2022
Q3
Sell
-37
Closed -$1K 2628
2022
Q2
$1K Sell
37
-10
-21% -$1.07K ﹤0.01% 2362
2022
Q1
$7K Sell
47
-206
-81% -$42.3K ﹤0.01% 2263
2021
Q4
$56K Buy
+253
New +$74.2K ﹤0.01% 1705

Other funds holding PRAX

Nisa Investment Advisors's PRAX Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Praxis Precision Medicines (PRAX) stake by 2.7% in Q2 2026, selling an estimated $53.5K and leaving 6,111 shares worth $2.05M. The position accounts for 0.01% of the portfolio, ranked #616.

Nisa Investment Advisors first reported a position in PRAX in Q4 2021 and has held it in 12 quarters since. The position peaked at $2.29M in Q4 2025. 93 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Nisa Investment Advisors held 6,111 shares of Praxis Precision Medicines worth $2.05M as of Q2 2026.
  • Nisa Investment Advisors sold 169 Praxis Precision Medicines shares in Q2 2026, an estimated $53.5K.
  • Praxis Precision Medicines made up 0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #616 holding.
  • Nisa Investment Advisors first reported a position in Praxis Precision Medicines in Q4 2021 and has held it in 12 quarters since.
  • Nisa Investment Advisors's Praxis Precision Medicines position peaked at $2.29M in Q4 2025.
  • 93 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.